OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex molecules. Enhancing these processes involves modifying various factors, including cell line development, media formulation, and bioreactor conditions. A key goal is to amplify antibody production while lowering production expense